| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $11.5M | -1.2% | -8.3% |
| Cost of Revenue | $4.2M | +4.4% | +0.5% |
| R&D Expense | $2.4M | -5.2% | -23.7% |
| SG&A Expense | $2.9M | +19.4% | +9.7% |
| Operating Income | -$941K | -75.6% | -14.1% |
| Pre-tax Income | -$993K | -1203.3% | -23.2% |
| Income Tax | $27K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $10.3M | -1.6% | -14.5% |
| Accounts Receivable | $7.4M | -2.2% | -4.7% |
| Current Assets | $20.4M | -3.3% | -6.4% |
| Total Assets | $41.1M | -2.0% | -6.6% |
| Current Liabilities | $8.1M | -7.6% | -6.9% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.5M | — | — |
| Capital Expenditures | $31K | — | — |
| Investing Cash Flow | -$892K | — | — |
| Financing Cash Flow | -$25K | — | — |
| Free Cash Flow | -$1.6M | — | — |
| +440.0% |
| +8.0% |
| Net Income | -$1.0M | -1300.0% | -22.7% |
| EPS (Basic) | -$0.02 | — | +0.0% |
| EPS (Diluted) | -$0.02 | — | +0.0% |
| $9.2M |
| -7.4% |
| -7.6% |
| Stockholders' Equity | $31.9M | -0.3% | -6.4% |